Guardian Capital LP Purchases Shares of 2,814 Aetna Inc (AET)
Guardian Capital LP purchased a new position in Aetna Inc (NYSE:AET) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 2,814 shares of the company’s stock, valued at approximately $447,000.
Several other institutional investors and hedge funds also recently bought and sold shares of AET. Wells Fargo & Company MN raised its position in Aetna by 4.2% in the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after buying an additional 54,928 shares during the last quarter. State of Tennessee Treasury Department raised its position in Aetna by 26.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after buying an additional 116,280 shares during the last quarter. Fayez Sarofim & Co. raised its position in Aetna by 82.8% in the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock worth $1,181,000 after buying an additional 3,365 shares during the last quarter. Banque Pictet & Cie SA purchased a new position in Aetna in the 2nd quarter worth about $10,567,000. Finally, Pictet & Cie Europe SA purchased a new position in Aetna in the 2nd quarter worth about $2,269,000. 88.01% of the stock is owned by hedge funds and other institutional investors.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Inc (AET) opened at $179.11 on Thursday. The stock has a market capitalization of $59,138.27, a P/E ratio of 17.76, a P/E/G ratio of 1.65 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna Inc has a 52 week low of $116.04 and a 52 week high of $192.37.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the prior year, the company posted $2.07 EPS. The firm’s revenue for the quarter was down 5.0% compared to the same quarter last year. research analysts predict that Aetna Inc will post 9.78 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 annualized dividend and a yield of 1.12%. Aetna’s payout ratio is 37.04%.
AET has been the subject of a number of recent analyst reports. Morgan Stanley boosted their target price on Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Argus reaffirmed a “buy” rating and set a $185.00 price target (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Jefferies Group upped their price target on shares of Aetna from $163.00 to $165.00 and gave the company a “hold” rating in a research report on Friday, October 13th. Finally, BMO Capital Markets initiated coverage on shares of Aetna in a research report on Monday, October 16th. They set a “market perform” rating and a $175.00 price target for the company. Twelve equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $175.19.
TRADEMARK VIOLATION WARNING: “Guardian Capital LP Purchases Shares of 2,814 Aetna Inc (AET)” was reported by Daily Political and is owned by of Daily Political. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.dailypolitical.com/2017/12/14/guardian-capital-lp-purchases-shares-of-2814-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.